Evidence map›Paper›PMID 29279490›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Renal Mucinous Tubular and Spindle Cell Carcinoma Shows a High Uptake on

Sho Furuya, Osamu Manabe, Toshikazu Nanbu, Noboru Yamashita, Yuuichirou Shinnno, Kiyoshi Kasai, Markus Kroenke, Nagara Tamaki

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Role ofJapanese journal of radiology · 2025
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Sho FuruyaDepartment of Radiology, Otaru General Hospital, Japan.
Osamu ManabeDepartment of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Japan.
Toshikazu NanbuDepartment of Radiology, Otaru General Hospital, Japan.
Noboru YamashitaDepartment of Urology, Otaru General Hospital, Japan.
Yuuichirou ShinnnoDepartment of Urology, Otaru General Hospital, Japan.
Kiyoshi KasaiDepartment of Diagnostic Pathology, Otaru General Hospital, Japan.
Markus KroenkeDepartment of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Japan.
Nagara TamakiDepartment of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Japan.
Otaru Municipal Hospital · JPHokkaido University · JPKlinikum rechts der Isar · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We herein report a rare case of mucinous tubular and spindle cell carcinoma (MTSCC) in an 80-year-old woman. A well circumscribed tumor located on the right kidney was discovered incidentally as a result of screening non-contrast CT. Fluorodeoxyglucose positron emission tomography (FDG PET)/CT showed the increased tracer accumulation in the tumor. The histological diagnosis was MTSCC, which is a rare and only recently established subtype of the malignant renal cell carcinoma (RCC). The present case suggests the clinical benefit of a high uptake of FDG combined with enhanced contrast CT in the differentiation of MTSCCs and other RCCs.

Indexed as

Adenocarcinoma, MucinousAged, 80 and overCarcinoma, Renal CellFemaleFluorodeoxyglucose F18HumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18FDG PET/CTmucinous tubular and spindle cell carcinomarenal cell carcinoma

Identifiers

PMID29279490
PMCPMC5938505
OpenAlexW2779076747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.